Triple

T11074694
Position Surface form Disambiguated ID Type / Status
Subject Docetaxel E261833 entity
Predicate developedBy P73 FINISHED
Object Rhône-Poulenc Rorer
Rhône-Poulenc Rorer was a major French-American pharmaceutical company known for developing important cancer therapies and later becoming part of Sanofi through mergers.
 E902895 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Rhône-Poulenc Rorer | Statement: [Docetaxel, developedBy, Rhône-Poulenc Rorer]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Rhône-Poulenc Rorer
Context triple: [Docetaxel, developedBy, Rhône-Poulenc Rorer]
  • A. Smith, Kline & French
    Smith, Kline & French was a major 20th-century pharmaceutical company known for developing and marketing important prescription drugs before becoming part of GlaxoSmithKline.
  • B. Schering
    Schering is a German surname most notably associated with Ernst Schering, a 19th-century pharmacist and founder of the pharmaceutical company Schering AG.
  • C. Roche
    Roche is a common surname of French origin borne by various notable individuals across fields such as architecture, politics, and the arts.
  • D. Roche
    Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
  • E. Ciba-Geigy
    Ciba-Geigy was a major Swiss pharmaceutical and chemical company that became one of the predecessors of Novartis after its merger with Sandoz in 1996.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Rhône-Poulenc Rorer
Triple: [Docetaxel, developedBy, Rhône-Poulenc Rorer]
Generated description
Rhône-Poulenc Rorer was a major French-American pharmaceutical company known for developing important cancer therapies and later becoming part of Sanofi through mergers.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Rhône-Poulenc Rorer
Target entity description: Rhône-Poulenc Rorer was a major French-American pharmaceutical company known for developing important cancer therapies and later becoming part of Sanofi through mergers.
  • A. Smith, Kline & French
    Smith, Kline & French was a major 20th-century pharmaceutical company known for developing and marketing important prescription drugs before becoming part of GlaxoSmithKline.
  • B. Schering
    Schering is a German surname most notably associated with Ernst Schering, a 19th-century pharmacist and founder of the pharmaceutical company Schering AG.
  • C. Roche
    Roche is a common surname of French origin borne by various notable individuals across fields such as architecture, politics, and the arts.
  • D. Roche
    Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
  • E. Ciba-Geigy
    Ciba-Geigy was a major Swiss pharmaceutical and chemical company that became one of the predecessors of Novartis after its merger with Sandoz in 1996.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d6aa9983c08190b0ef61603b69feac completed April 8, 2026, 7:20 p.m.
NER Named-entity recognition batch_69d7994efb608190a81bc8c4d16ddbd0 completed April 9, 2026, 12:19 p.m.
NED1 Entity disambiguation (via context triple) batch_69e3c8cc77988190aad54f56dbd0f8cf completed April 18, 2026, 6:09 p.m.
NEDg Description generation batch_69e3cefc00148190a1850dc6e31523c3 completed April 18, 2026, 6:35 p.m.
NED2 Entity disambiguation (via description) batch_69e3d014a644819092c76aa02b573ca9 completed April 18, 2026, 6:40 p.m.
Created at: April 8, 2026, 9:26 p.m.